跳至主要内容
临床试验/NCT00308906
NCT00308906已完成不适用

Assessment of Gene and Urinary Protein Expression in Aminoglycoside-treated and Untreated Infants, Children and Adolescents

Virginia Commonwealth University2 个研究点 分布在 1 个国家目标入组 166 人开始时间: 2006年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
166
试验地点
2
主要终点
Indicators of renal injury

研究概览

简要总结

The purposes of this study are to identify potential gene and protein markers of aminoglycoside-induced kidney injury in infants, children and adolescents treated with aminoglycoside antibiotics.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • (1) Hospitalized male and female newborns, infants, children and adolescents (ages birth to 18 years) with a diagnosis of suspected or proven bacterial sepsis, meningitis or other indication necessitating aminoglycoside therapy (2) hospitalized and outpatient newborns, infants, children and adolescents (ages birth to 18 years) who are not receiving aminoglycoside therapy.

排除标准

  • (1) Current treatment with inhaled or ophthalmic aminoglycosides (2) Prior treatment with an aminoglycoside within the last 30 days

研究组 & 干预措施

1

Hospitalized, untreated infants and children

干预措施: aminoglycoside (Drug)

2

Aminoglycoside treated infants and children without renal injury

干预措施: aminoglycoside (Drug)

3

Aminoglycoside treated infants with renal injury

干预措施: aminoglycoside (Drug)

结局指标

主要结局

Indicators of renal injury

时间窗: Pre and post treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mary Jayne Kennedy

Associate Professor

Virginia Commonwealth University

研究点 (2)

Loading locations...

相似试验